SCHEMBL17878555

SCHEMBL17878555

CCCC(OC(=O)CCC(C)C)C(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.40
CA1 P00915 2/20 0.39
MAPT P10636 2/20 0.34
MAPK1 P28482 1/20 0.34
ALDH1A1 P00352 2/20 0.33
MMP1 P03956 1/20 0.32
MMP2 P08253 1/20 0.32
MMP3 P08254 1/20 0.32
MMP9 P14780 1/20 0.32
MMP13 P45452 1/20 0.32
CHRM1 P11229 1/20 0.31
AKR1A1 P14550 1/20 0.31
CHRM3 P20309 1/20 0.31
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
ADRA1A P35348 1/20 0.31
HRH1 P35367 1/20 0.31
DRD3 P35462 1/20 0.31
SLC6A3 Q01959 1/20 0.31
HDAC1 Q13547 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757907 0.90 LMNA (0.44) LMNAMAPTMAPK1ALDH1A1CHRM1
SCHEMBL17878557 0.89 LMNA (0.46) LMNACA1MAPTMAPK1ALDH1A1
SCHEMBL17882020 0.88 ALDH1A1 (0.44) LMNAMAPTMAPK1ALDH1A1CHRM1
SCHEMBL17878556 0.86 CA1 (0.40) LMNACA1MAPTMAPK1ALDH1A1
SCHEMBL17860698 0.83 LMNA (0.39) LMNAMAPTMAPK1ALDH1A1CHRM1
SCHEMBL17878538 0.80 LMNA (0.42) LMNACA1MAPTMAPK1ALDH1A1
SCHEMBL17878552 0.80 MAPT (0.44) LMNACA1MAPTMAPK1ALDH1A1
SCHEMBL30547122 0.80 LMNA (0.42) LMNACA1MAPTMAPK1ALDH1A1
SCHEMBL14991338 0.77 CHRM1 (0.37) LMNACA1ALDH1A1CHRM1AKR1A1
SCHEMBL24593948 0.77 LMNA (0.53) LMNAMAPTMAPK1ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233889-B1 ANTIMICROBIAL POLYMYXINS FOR TREATMENT OF BACTERIAL INFECTIONS SHANGHAI MICURX PHARMACEUTICAL CO LTD (CN) 2022-07-06 EP disclosed
US-9771394-B2 Antimicrobial polymyxins for treatment of bacterial infections MICURX PHARMACEUTICALS, INC. (KY) 2017-09-26 US disclosed
US-20160185823-A1 ANTIMICROBIAL POLYMYXINS FOR TREATMENT OF BACTERIAL INFECTIONS MICURX PHARMACEUTICALS, INC. 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160185823-A1 ANTIMICROBIAL POLYMYXINS FOR TREATMENT OF BACTERIAL INFECTIONS VIP, AQP1, PEF1 LMNA 660/4885CA1 4817/4885MAPT 4274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.